RxSight, Inc. (RXST) Dividend History

RxSight, Inc. is a medical device company specializing in the development and commercialization of innovative ophthalmic products. Its primary focus is on improving outcomes for patients undergoing cataract surgery through its flagship product, the Light Adjustable Lens (LAL), which allows customization and post-operative adjustments to optimize visual results. The company’s technology aims to enhance the precision and flexibility of cataract treatment.

100 Columbia Street, Aliso Viejo, CA, 92656
Phone: 949-521-7822
Website: https://www.rxsight.com

Dividend History

RxSight, Inc. currently does not pay dividends

Company News

RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead the RxSight Class Action Lawsuit

RxSight faces class action lawsuit alleging false financial statements and misleading investors about product adoption and sales performance, with stock price dropping 38% after revealing significant revenue challenges.

GlobeNewswire Inc.
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST

Law firm DJS Law Group is investigating potential securities law violations by RxSight after the company reported significant financial declines, including reduced device sales and lowered annual guidance, which caused its stock to drop nearly 38%.

Benzinga
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?

Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research
RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript

RXST earnings call for the period ending June 30, 2022.

The Motley Fool
RxSight, Inc. (RXST) CEO Ron Kurtz on Q1 2022 Results - Earnings Call Transcript

RxSight, Inc. (NASDAQ:NASDAQ:RXST) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Philip Taylor - Investor Relations Ron Kurtz - President and Chief Executive...

Seeking Alpha

Page data last updated 07/23/2025 16:19:57 UTC